Hopp til hovedinnhold


Sist oppdatert: Sist revidert:
Sist revidert av:

  1. Vakil N. Assessment of dyspepsia. BMJ Best Practice, last reviewed 7 Nov 2021. bestpractice.bmj.com  
  2. Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013. PubMed  
  3. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Oct 2019. www.nice.org.uk  
  4. Chassany O, Shaheen NJ, Karlsson M, et al. Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia. Scand J Gastroenterol. 2012;47:1412-1421. PubMed  
  5. Gastroduodenal disorders. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroenterology. 2016;150:1380–1392. PMID: 27147122 PubMed  
  6. Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015 Jul;64(7):1049-57. PubMed  
  7. Hospital admissions and primary care attendances for nonulcer dyspepsia, reflux oesophagitis and peptic ulcer in Scotland 1981-2004. Baron JH, Sonnenberg A. Eur J Gastroenterol Hepatol. 2008;20:180–186. PMID: 18301297 PubMed  
  8. American Gastroenterological Association technical review on the evaluation of dyspepsia. Talley NJ, Vakil NB, Moayyedi P. Gastroenterology. 2005;129:1756–1780.
  9. Faintuch JJ, Silva FM, Navarro-Rodriguez T, et al. Endoscopic findings in uninvestigated dyspepsia. BMC Gastroenterol. 2014;14:19. Published 2014 Feb 6. PMID: 24499444 PubMed  
  10. Kavitt RT, Lipowska AM, Anyane-Yeboa A, Gralnek IM. Diagnosis and Treatment of Peptic Ulcer Disease. Am J Med. 2019;132(4):447-456. PubMed  
  11. Yap PR, Goh KL. Non-steroidal anti-inflammatory drugs (NSAIDs) induced dyspepsia. Curr Pharm Des. 2015;21(35):5073-81. PubMed  
  12. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and metaanalysis. Gastroenterology. 2006;131:390–401. PMID: 16890592 PubMed  
  13. Zagari RM, Law GR, Fuccio L, Pozzato P, Forman D, Bazzoli F. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol 2010; 105: 565-71. PubMed  
  14. Dyspepsi og Helicobacter pylori-infeksjon. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Helsedirektoratet, 16.11.2021. www.helsedirektoratet.no  
  15. Valle PC, Breckan RK, Amin A, et al. "Test, score and scope": A selection strategy for safe reduction of upper gastrointestinal endoscopies in young dyspeptic patients referred from primary care. Scand J Gastroenterol 2006; 41: 161-9. PubMed  
  16. Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018 Mar 15;(3):CD012080. Cochrane (DOI)  
  17. Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH. Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology. J Res Med Sci. 2011;16(9):1097-1104. PubMed  
  18. Løvlund EE, Størdal K. Helicobacter pylori. Generell veileder i pediatri. Sist revidert 2017. www.helsebiblioteket.no  
  19. Eusebi LH, Black CJ, Howden CW, Ford AC. Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis. BMJ 2019;367:l6483. www.bmj.com  
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Hermod Petersen, professor og overlege, Norges teknisk-naturvitenskapelige universitet og Medisinsk avdeling, Regionsykehuset i Trondheim